Select a Region North America

Content Library

Articles

Simulated treatment comparison of efficacy outcomes for ofatumumab in ASCLEPIOS I/II versus ocrelizumab in OPERA I/II for the treatment of patients with relapsing multiple sclerosis
A systematic review and network meta‐analysis comparing ofatumumab with other disease‐modifying therapies available in Japan for the treatment of patients with relapsing multiple sclerosis
An economic evaluation of cabazitaxel versus a second androgen receptor-targeted agent (ARTA) for patients with metastatic castration-resistant prostate cancer previously treated with docetaxel and an ARTA: the United States payer perspective
Healthcare and economic burden of anticholinergic use in adults with overactive bladder: a systematic literature review
Comparative assessment of heads-up display and conventional surgical microscope for ergonomic and other benefits in posterior-segment surgeons
Health Care Resource Utilization With Asciminib And Bosutinib Among Adults With Chronic Myeloid Leukemia In Chronic Phase Previously Treated With ≥2 Tyrosine Kinase Inhibitors: Results From ASCEMBL Trial
Use of Cost per Responder Models for CAR-T Therapies in Relapsed or Refractory Multiple Myeloma
Comparing the Change from Base Case to Re-Analyzed ICER Values for CADTH Oncology Evaluations
Letter to the Editor Regarding “Network Meta-analysis of Food and Drug Administration-approved Treatment Options for Adults with Aquaporin-4 Immunoglobulin G-positive Neuromyelitis Optica Spectrum Disorder
The burden of red blood cell transfusions in patients with lower-risk myelodysplastic syndromes and ring sideroblasts: an analysis of the prospective MDS-CAN registry